Treatment decisions for metastatic castration-resistant prostate cancer progressing after docetaxel chemotherapy: the role of cabazitaxel in the continuum of care

Eur Urol. 2012 Dec;62(6):1201-4. doi: 10.1016/j.eururo.2012.08.048. Epub 2012 Aug 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Continuity of Patient Care
  • Docetaxel
  • Drug Resistance, Neoplasm*
  • Humans
  • Male
  • Neoplasm Metastasis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Taxoids / therapeutic use*

Substances

  • Antineoplastic Agents
  • Taxoids
  • Docetaxel
  • cabazitaxel